BYNFEZIA PEN Drug Patent Profile
✉ Email this page to a colleague
When do Bynfezia Pen patents expire, and what generic alternatives are available?
Bynfezia Pen is a drug marketed by Sun Pharm and is included in one NDA. There are four patents protecting this drug.
This drug has six patent family members in six countries.
The generic ingredient in BYNFEZIA PEN is octreotide acetate. There are twenty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bynfezia Pen
A generic version of BYNFEZIA PEN was approved as octreotide acetate by WEST-WARD PHARMS INT on April 8th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BYNFEZIA PEN?
- What are the global sales for BYNFEZIA PEN?
- What is Average Wholesale Price for BYNFEZIA PEN?
Summary for BYNFEZIA PEN
International Patents: | 6 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
What excipients (inactive ingredients) are in BYNFEZIA PEN? | BYNFEZIA PEN excipients list |
DailyMed Link: | BYNFEZIA PEN at DailyMed |

Pharmacology for BYNFEZIA PEN
Drug Class | Somatostatin Analog |
Mechanism of Action | Somatostatin Receptor Agonists |
US Patents and Regulatory Information for BYNFEZIA PEN
BYNFEZIA PEN is protected by ten US patents.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm | BYNFEZIA PEN | octreotide acetate | SOLUTION;SUBCUTANEOUS | 213224-001 | Sep 27, 2024 | RX | Yes | Yes | 11,246,991 | ⤷ Try for Free | ⤷ Try for Free | ||||
Sun Pharm | BYNFEZIA PEN | octreotide acetate | SOLUTION;SUBCUTANEOUS | 213224-001 | Sep 27, 2024 | RX | Yes | Yes | 11,052,196 | ⤷ Try for Free | ⤷ Try for Free | ||||
Sun Pharm | BYNFEZIA PEN | octreotide acetate | SOLUTION;SUBCUTANEOUS | 213224-001 | Sep 27, 2024 | RX | Yes | Yes | 11,534,553 | ⤷ Try for Free | ⤷ Try for Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for BYNFEZIA PEN
See the table below for patents covering BYNFEZIA PEN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 3624829 | INJECTION D'OCTRÉOTIDE (OCTREOTIDE INJECTION) | ⤷ Try for Free |
China | 110678194 | 奥曲肽注射液 (Octreotide injection) | ⤷ Try for Free |
World Intellectual Property Organization (WIPO) | 2018211526 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Market Dynamics and Financial Trajectory for Bynfezia Pen
More… ↓